Regeneron (REGN) Reports Dupixent Recommended for EU Approval by the CHMP
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Regeneron (NASDAQ: REGN) | Delayed: 819.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $819.09 | 52 Week High | $592.36 | |||
| Open | $819.09 | 52 Week Low | $325.35 | |||
| Day High | $819.09 | P/E | 214.98 | |||
| Day Low | $819.09 | EPS | $3.81 | |||
| Volume | 399 | |||||
